Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The study aims to evaluate the safety and efficacy of the combination of topical baricitinib and 308-nm monochromatic excimer light versus 308-nm monochromatic excimer light alone in treatment of non-segmental vitiligo.
Epistemonikos ID: ffff595f01a5a4c93e1d6e8dc0d50680d2caf75d
First added on: May 15, 2024